{
  "schemaVersion": 1,
  "contentDigest": "847ee49018c9152ae7eef6f7d37c405fedaa5cf211a88a70a7a42a802be55c7b",
  "id": "news-oct22-a2-abu-dhabi-local-biosimilar-manufacturing-2026-10-20",
  "language": "en",
  "interfaceLanguage": "en",
  "url": "https://voltformer.com/news/adcan-ms-pharma-plan-uae-local-medicine-manufacturing",
  "slug": "adcan-ms-pharma-plan-uae-local-medicine-manufacturing",
  "category": "policy-standards",
  "publishDate": "2026-10-20",
  "sourceName": "Emirates News Agency (WAM)",
  "sourceUrl": "https://www.wam.ae/en/article/c2u6pr6-adcan-pharma-pharma-partner-advance-pharmaceutical",
  "readingTimeMinutes": 1,
  "tags": [
    "United Arab Emirates",
    "Pharmaceuticals",
    "Manufacturing",
    "Healthcare"
  ],
  "content": {
    "title": "ADCAN Pharma and MS Pharma plan UAE medicine production",
    "summary": "The proposed framework covers biosimilars, injectables and oral medicines.",
    "sections": [
      {
        "paragraphs": [
          "ADCAN Pharma and MS Pharma plan to localise medicines in the UAE. Their proposed framework covers manufacturing, packaging, testing and batch release for biosimilars, injectables and oral solid-dose products, including therapies for oncology, immunology and cardiovascular conditions."
        ],
        "sources": [
          {
            "name": "Emirates News Agency (WAM)",
            "url": "https://www.wam.ae/en/article/c2u6pr6-adcan-pharma-pharma-partner-advance-pharmaceutical"
          }
        ]
      }
    ]
  },
  "companies": [],
  "sourceVersion": "e5877c03afd7520368adf1e7894a4f36e5aaa48fe2768975f154461358bda472"
}